Shockwave Medical
  • Technology
    • Challenges of Calcium
    • Intravascular Lithotripsy (IVL)
    • IVL Mechanism of Action
  • Clinicians
    • USA
    • Peripheral
      reimbursement Peripheral Reimbursement
      • Pre-TAVI
      • Pre-EVAR
      • Iliac
      • Common Femoral
      • Femoropopliteal
      • Infrapopliteal
      • Clinical Evidence
        • PAD I
        • PAD II
        • PAD III
        • BTK
      • PAD Case Library
      • Product Specs & Resources
        • Shockwave M5
    • reimbursement Peripheral Reimbursement
    • Coronary
      reimbursement Coronary Reimbursement
    • reimbursement Coronary Reimbursement
    • Transfemoral Access
      • Pre-TAVR
      • Pre-EVAR/TEVAR
    • International
    • Peripheral
      • Pre-TAVR
      • Pre-EVAR
      • Iliac
      • Common Femoral
      • Femoropopliteal
      • Infrapopliteal
      • Clinical Evidence
        • PAD I
        • PAD II
        • PAD III
        • BTK
      • PAD Case Library
      • Product Specs & Resources
        • Shockwave M5
    • Coronary
      • CAD Case Library
      • Clinical Evidence
        • CAD I
        • CAD II
        • CAD III
      • Product Specs & Resources
        • Shockwave C2
    • Transfemoral Access
      • Pre-TAVI
      • Pre-EVAR/TEVAR
  • Education
    • Calcium IVLeague
    • The Catalyst
  • Resources
    • IFU Portal
    • Peripheral Reimbursement
    • Coronary IVL Reimbursement
  • Investors
    • Overview
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
    • Investor Resources
  • About
    • Our Story
    • People
    • Careers
    • Patents
    • Press Releases
    • Contact
Home Education Blog
catalyst_logo

Welcome to The Catalyst

Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.

ico email Connect
Topic: DISRUPT CAD

New IVL Trilogy in JACC Interventions – Hear the Highlights

Learn about IVL’s unique mechanism of action in fracturing severe, superficial and deep calcium and...

Read More

A Patient-level Pooled Analysis of the Disrupt CAD I, II, III and IV Studies: Q&A with Dr. Robert Riley

We had the privilege of connecting with Dr. Robert Riley Director, Complex Coronary Therapeutics...

Read More

CAD III ShockTalk: A Discussion about the Data’s Significance

At TCT Connect, investigators presented the 30-day primary endpoint analysis of the Disrupt CAD III...

Read More

DISRUPT CAD III Q&A with Co-PI Dr. Jonathan Hill

Following its presentation as a late-breaking clinical at TCT Connect and simultaneous publication...

Read More

Q&A: Dr. Kereiakes Shares Perspective on DISRUPT CAD III Design

Last month the DISRUPT CAD III investigators, led by co-PIs Drs. Dean Kereiakes and Jonathan Hill,...

Read More

It’s Good to Be Eccentric…When Trying to Treat Eccentric Calcium

If Shockwave IVL had a personality, we’d like to think that we’d be a bit on the eccentric side. A...

Read More
Topics
  • CAD Applications - Bifurcations
  • CAD Applications - Eccentric Lesions
  • Calcium Corner
  • ChalkTalk Podcast
  • Clinical Corner with Dr. Keith Dawkins
  • Clinical Corner with SW
  • Coronary Cases
  • Coronary Clinical Data
  • Coronary Conferences
  • Coronary IVL
  • Coronary IVL - U.S.
  • DISRUPT CAD
  • DISRUPT PAD
  • Insider
  • IVL Case
  • IVL Technology
  • Medical Meetings
  • PAD Applications - BTK
  • PAD Applications - CLI
  • PAD Applications - EVAR
  • PAD Applications - Iliac
  • PAD Applications - TAVR Access
  • PAD Applications - TEVAR
  • Peripheral Cases
  • Peripheral Clinical Data
  • Peripheral Conferences
  • Peripheral IVL
  • PulsePoint Newsletter
  • Q&A with Uday
  • Shockwave Behind-the-Scenes
  • Shockwave Breaking News
  • Shockwave C2
  • Shockwave M5
  • Shockwave S4
  • ShockwaveM5+
  • SWAV News

New IVL Trilogy in JACC Interventions – Hear the Highlights

Posted by Emma Miller on Jun 28, 2021 8:41:44 AM
  • Tweet

Learn about IVL’s unique mechanism of action in fracturing severe, superficial and deep calcium and the clinical outcomes associated with IVL in the coronary and peripheral vasculature.

 

Read More
0 Comments Click here to read/write comments

Topics: DISRUPT CAD, IVL Technology, DISRUPT PAD, Coronary Clinical Data, Peripheral Clinical Data

A Patient-level Pooled Analysis of the Disrupt CAD I, II, III and IV Studies: Q&A with Dr. Robert Riley

Posted by Emma Miller on May 17, 2021 3:10:59 PM
  • Tweet

We had the privilege of connecting with Dr. Robert Riley Director, Complex Coronary Therapeutics Program, The Christ Hospital Health System. Dr. Riley is the leading author of the abstract for the Patient-Level Pooled Analysis of the Disrupt CAD I, II, III and IV studies and presented at ACC.21 Virtual.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, DISRUPT CAD, Coronary Cases, Coronary Clinical Data, Shockwave C2, Coronary Conferences

CAD III ShockTalk: A Discussion about the Data’s Significance

Posted by Emma Miller on Dec 29, 2020 1:49:53 PM
  • Tweet

At TCT Connect, investigators presented the 30-day primary endpoint analysis of the Disrupt CAD III study, the largest and most rigorous coronary IVL study to date.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, DISRUPT CAD, Coronary Cases, Coronary Clinical Data

DISRUPT CAD III Q&A with Co-PI Dr. Jonathan Hill

Posted by Emma Miller on Oct 15, 2020 9:35:37 AM
  • Tweet

Following its presentation as a late-breaking clinical at TCT Connect and simultaneous publication in the Journal of the American College of Cardiology (JACC) we sat down with Dr. Jonathan Hill, Consultant Cardiologist at the Royal Brompton Hospital in London, to get his perspective on the results, how they build on CAD I & II outcomes, and where they fit into clinician’s daily decision-making process when treating calcified lesions. We hope you enjoy his perspective.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, DISRUPT CAD, Coronary Clinical Data, Shockwave C2, Coronary Conferences

Q&A: Dr. Kereiakes Shares Perspective on DISRUPT CAD III Design

Posted by Emma Miller on Aug 26, 2020 9:01:31 AM
  • Tweet

Last month the DISRUPT CAD III investigators, led by co-PIs Drs. Dean Kereiakes and Jonathan Hill, published in the American Heart Journal the trial design and rationale paper titled, “Evaluation of safety and efficacy of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: Design and rationale for the Disrupt CAD III trial.”

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, DISRUPT CAD, Coronary Clinical Data

It’s Good to Be Eccentric…When Trying to Treat Eccentric Calcium

Posted by Emma Miller on Jul 1, 2020 1:07:09 PM
  • Tweet

If Shockwave IVL had a personality, we’d like to think that we’d be a bit on the eccentric side. A little unconventional and taking a slightly different path than everyone else. After all, you won’t be successful in introducing a new disruptive technology if you’re marching to the same drumbeat as everyone else.

Read More
0 Comments Click here to read/write comments

Topics: DISRUPT CAD, Coronary Cases, Shockwave C2, Coronary Conferences, CAD Applications - Eccentric Lesions

All posts

We're excited about IVL's potential in aortic stenosis, too!

But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.

MORE ON TAVR ENABLING TRANSFEMORAL ACCESS
SIGN UP FOR UPDATES ON OUR VALVE R&D PROGRAM

Get Crackin with Shockwave IVL Today

To keep you apprised of the latest IVL news, education, and cases, please share your selected interests.

Shockwave Medical

Corporate Headquarters
5403 Betsy Ross Drive
Santa Clara, CA 95054
United States

1-877-77-LITHO (775-4846)

info@shockwavemedical.com

  • Technology
    • Challenges of Calcium
  • Applications
    • US
    • Peripheral
    • Coronary
    • TF Access
    • International
    • Peripheral
    • Coronary
    • TF Access
  • Education
    • Ca++ IVLeague
    • The Catalyst
  • Resources
    • IFU Portal
    • Peripheral Reimbursement
    • Coronary Reimbursement
  • Investors
  • About Us
    • Our Story
    • People
    • Careers
    • Patents
    • Press Releases
    • Contact
Follow us

Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions and adverse events.

  • Privacy Policy
  • ISI
  • Patents

© 2022 Shockwave Medical Inc. All rights reserved. | SPL 63081 Rev. A